Dr.reddy's Laboratories Ltd — Nivolumab Exporter Profile
Indian Pharmaceutical Exporter · #1 for Nivolumab · $577.4K export value · DGFT Verified
Dr.reddy's Laboratories Ltd is the #1 Indian exporter of Nivolumab with $577.4K in export value and 15 verified shipments. Dr.reddy's Laboratories Ltd holds a 25.3% market share in Nivolumab exports across 5 countries.
Dr.reddy's Laboratories Ltd — Nivolumab Export Profile: Buyers & Destinations
Where Does Dr.reddy's Laboratories Ltd Export Nivolumab?
| Country | Value | Shipments | Share |
|---|---|---|---|
| RUSSIA | $300.0K | 6 | 93.2% |
| UNITED KINGDOM | $20.9K | 1 | 6.5% |
| UNITED STATES | $775 | 4 | 0.2% |
| NETHERLANDS | $30 | 2 | 0.0% |
| GERMANY | $20 | 2 | 0.0% |
Dr.reddy's Laboratories Ltd exports Nivolumab to 5 countries. The largest destination is RUSSIA accounting for 93.2% of Dr.reddy's Laboratories Ltd's Nivolumab shipments, followed by UNITED KINGDOM (6.5%) and UNITED STATES (0.2%). These destinations reflect Dr.reddy's Laboratories Ltd's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Nivolumab from Dr.reddy's Laboratories Ltd?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| COREX LLC | RUSSIA | $300.0K | 6 |
| LABCORP EARLY DEVELOPMENT | UNITED KINGDOM | $20.9K | 1 |
| BIOPHARMASPEC INC | UNITED STATES | $525 | 3 |
| CHARLES RIVER LABORATORIES,INC., | UNITED STATES | $250 | 1 |
| CERGENTIS B.V. | NETHERLANDS | $30 | 2 |
| PROTAGENE GMBH | GERMANY | $20 | 2 |
Dr.reddy's Laboratories Ltd supplies Nivolumab to 6 buyers globally. The largest buyer is COREX LLC (RUSSIA), followed by LABCORP EARLY DEVELOPMENT (UNITED KINGDOM) and BIOPHARMASPEC INC (UNITED STATES). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Nivolumab Export Value and How Much Does Dr.reddy's Laboratories Ltd Contribute?
India exported $946.0K worth of Nivolumab through 144 shipments from 23 suppliers to 13 countries, serving 47 buyers globally. Dr.reddy's Laboratories Ltd contributes $577.4K to this total, accounting for 25.3% of India's Nivolumab exports. Dr.reddy's Laboratories Ltd ships Nivolumab to 5 countries through 6 buyers.
What Is the Average Shipment Value for Dr.reddy's Laboratories Ltd's Nivolumab Exports?
Dr.reddy's Laboratories Ltd's average Nivolumab shipment value is $38.5K per consignment, based on 15 shipments totaling $577.4K. The largest destination is RUSSIA (93.2% of Dr.reddy's Laboratories Ltd's Nivolumab exports).
How Does Dr.reddy's Laboratories Ltd Compare to Other Indian Nivolumab Exporters?
Dr.reddy's Laboratories Ltd ranks #1 among 23 Indian Nivolumab exporters with a 25.3% market share. The top 3 exporters are DR.REDDY'S LABORATORIES LTD ($577.4K), CORSANTRUM TECHNOLOGY ($115.1K), VAMA LIFECARE PRIVATE LIMITED ($72.9K). Dr.reddy's Laboratories Ltd processed 15 shipments to 5 destination countries.
What Nivolumab Formulations Does Dr.reddy's Laboratories Ltd Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| NIVOLUMAB 100MG/10ML-FOR TESTING PURPOSEONLY | $150.0K | 3 |
| NIVOLUMAB 40MG/4ML-FOR TESTING PURPOSE ONLY | $150.0K | 3 |
| NIVOLUMAB 100MG/10 ML(QTY:30 VIALS)(FORTESTING PURPOSE ONLY)VLS | $20.9K | 1 |
| NIVOLUMAB TEST SAMPLE-3(DRL-NIVOLUMAB)-1ML(QTY:01 VIAL) | $287 | 1 |
| NIVOLUMAB WCB VIAL(1.8 ML CRYOVIAL)(QTY:10 VIALS)(FOR TESTING USE SAMPLES ONLY) | $250 | 1 |
| NIVOLUMAB TEST SAMPLE-1(OPDIVO REFERENCEMEDICINAL PRODUCT)-1ML(QTY:01 VIAL) | $124 | 1 |
| NIVOLUMAB TEST SAMPLE-2(OPDIVO REFERENCEMEDICINAL PRODUCT)-1ML(QTY:01 VIAL) | $114 | 1 |
| NIVOLUMAB MCB(QTY:2 VIALS)(FOR TESTING PURPOSE ONLY) | $20 | 1 |
| NIVOLUMAB BUFFER-2-30ML(QTY:4 TUBES)(FORTESTING PURPOSE ONLY)NOS | $16 | 1 |
| NIVOLUMAB GENOMIC DNA-500MG(QTY: 1 VIALS)(FOR TESTING PURPOSE ONLY) | $10 | 1 |
Dr.reddy's Laboratories Ltd exports 11 distinct Nivolumab formulations including tablets, capsules, syrups, and combination drugs. The top formulation is NIVOLUMAB 100MG/10ML-FOR TESTING PURPOSEONLY with 3 shipments worth $150.0K.
Regulatory Requirements: Exporting Nivolumab to Key Markets
What Dr.reddy's Laboratories Ltd must comply with to export Nivolumab to its top destination countries
United Kingdom — MHRA
Approval Process
Post-Brexit UK Marketing Authorisation via national procedure. Separate from EU approval since January 2021.
Timeline: 12–15 months
GMP & Export Requirements
UK GMP compliance; MHRA inspection of manufacturing site
Manufacturer Import Authorisation (MIA) held by UK importer; Qualified Person (QP) batch release
Note: Post-Brexit: EU GMP certificates no longer automatically valid in UK. Separate MHRA recognition required.
United States — FDA
Approval Process
ANDA (Abbreviated New Drug Application) for generics. Indian manufacturing site must pass FDA pre-approval inspection. Drug Master File (DMF) required for APIs.
Timeline: 10–18 months for ANDA approval
GMP & Export Requirements
FDA cGMP compliance (21 CFR 210/211); facility inspection by FDA
Drug Listing with FDA; Export Certificate from CDSCO India; Import Alert screening via FDA PREDICT system
Note: Subject to FDA Import Alerts. Open Form 483 observations can block all exports from a facility.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
How Does Dr.reddy's Laboratories Ltd Compare to Nearest Nivolumab Exporters?
Exporters ranked immediately above and below #1 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 1 | DR.REDDY'S LABORATORIES LTD ★ | $577.4K | 15 | 5 | $38.5K |
| 2 | CORSANTRUM TECHNOLOGY | $115.1K | 22 | 1 | $5.2K |
| 3 | VAMA LIFECARE PRIVATE LIMITED | $72.9K | 7 | 1 | $10.4K |
Dr.reddy's Laboratories Ltd ranks #1 among 23 Indian Nivolumab exporters. Average shipment value of $38.5K compared to the market average of $41.1K. The closest competitors by value are CORSANTRUM TECHNOLOGY and VAMA LIFECARE PRIVATE LIMITED.
Which Indian Ports Ship Nivolumab Exports?
| Port | Shipments | % Share |
|---|---|---|
| AHEMDABAD AIR ACC (INAMD4) | 38 | 26.4% |
| SAHAR AIR | 27 | 18.8% |
| AHEMDABAD AIR | 15 | 10.4% |
| HYDERABAD AIR | 11 | 7.6% |
| SAHAR AIR CARGO ACC (INBOM4) | 11 | 7.6% |
| Ahmedabad Air | 8 | 5.6% |
| CHENNAI AIR CARGO ACC (INMAA4) | 5 | 3.5% |
| BANGALORE ACC (INBLR4) | 5 | 3.5% |
Market Intelligence
Latest developments and market context
Detailed market intelligence for Nivolumab — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Nivolumab shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Dr.reddy's Laboratories Ltd matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 15 individual customs records matching Dr.reddy's Laboratories Ltd exporting Nivolumab, covering 11 formulations to 5 countries via 6 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 13+ countries, 47+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Nivolumab Export Data from Dr.reddy's Laboratories Ltd
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Dr.reddy's Laboratories Ltd's Nivolumab exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Dr.reddy's Laboratories Ltd
Company Profile
0 products · $0 total trade · 0 categories
Nivolumab Stats
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Dr.reddy's Laboratories Ltd.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Nivolumab. For current shipment-level data, contact TransData Nexus.